-Arthur Zimmermann Researcher Activity Profile

Research Author Detailed Information 

Arthur Zimmermann Publication Rate By Year

Arthur Zimmermann has published 1 paper(s) in 2003, 1 paper(s) in 2006, 11 paper(s) in 2007, for a total of 13 research publications in total.

Arthur A Zimmermann Author Information

LAST NAME: zimmermann

FIRST NAME: arthur

INITIALS: A

AFFILIATION:

Papers

Arthur Zimmermann's Publication Record

1. Suppression of transforming growth factor beta signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations. Year Published: 2007
Department of Medicine and Pharmacology & Toxicology, Dartmouth Medical School, Hanover, New Hampshire, USA.
2. [Preferential expression of cartilage oligomeric matrix protein in degenerating acinar cells in chronic pancreatitis and in chronic pancreatitis-like lesions] Year Published: 2003
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
3. Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. Year Published: 2006
Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Murtenstrasse 31, P.O. Box 62, CH-3010 Bern, Switzerland.
4. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. Year Published: 2007
University Hospital of Bern, Gastroenterology Clinic, Bern, Switzerland.
5. Neurokinin-2 receptor levels correlate with intensity, frequency, and duration of pain in chronic pancreatitis. Year Published: 2007
Department of General Surgery, University of Heidelberg, Heidelberg, Germany.
6. Active caspase 3 and DNA fragmentation as markers for apoptotic cell death in primary and metastatic liver tumours. Year Published: 2007
Institute of Pathology.
7. Neurokinin-2 receptor levels correlate with intensity, frequency, and duration of pain in chronic pancreatitis. Year Published: 2007
Department of General Surgery, University of Heidelberg, Heidelberg, Germany.
8. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. Year Published: 2007
University Hospital of Bern, Gastroenterology Clinic, Bern, Switzerland.
9. A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major. Year Published: 2007
Ege University Faculty of Medicine, Department of Pediatric Hematology 35100 Bornova, Izmir, Turkey. yesim.aydinok@ege.edu.tr.
10. A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major. Year Published: 2007
Ege University, Faculty of Medicine, Department of Pediatric Hematology 35100 Bornova, Izmir, Turkey. yesim.aydinok@ege.edu.tr
11. Active caspase 3 and DNA fragmentation as markers for apoptotic cell death in primary and metastatic liver tumours. Year Published: 2007
Institute of Pathology, Flow Cytometry Facility, Department of Clinical Research, University of Bern, Switzerland.
12. Active caspase 3 and DNA fragmentation as markers for apoptotic cell death in primary and metastatic liver tumours. Year Published: 2007
Institute of Pathology, Flow Cytometry Facility, Department of Clinical Research, University of Bern, Switzerland.
13. A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major. Year Published: 2007
Ege University, Faculty of Medicine, Department of Pediatric Hematology 35100 Bornova, Izmir, Turkey. yesim.aydinok@ege.edu.tr